Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Altabax for MRSA Nasal Colonization
NCT00856089Phase 4Withdrawn
- Sponsor
- Ochsner Clinic Foundation
- Start
- May 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of retapamulin in Staphylococcus aureus colonization, sponsored by Ochsner Clinic Foundation. Planned start May 2009; status: withdrawn.
02
Drugs
retapamulin
03
Conditions
Staphylococcus aureus colonization
Beyond the preview
Go deeper on NCT00856089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00856089.